Characterization of Immune Cells and Their Secreted Cytokines in Endometriosis Patients

NCT ID: NCT06897436

Last Updated: 2025-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-01

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The EUmetriosis project aims to address the most important unmet needs of endometriosis sufferers to advance patient care. The objectives cover all main aspects of disease management, including elucidating the pathogenesis, diagnosing the condition promptly and efficiently, facilitating care by implementing self-management strategies, raising awareness and promoting policy changes. The objectives comprise individual yet intersecting pieces of a puzzle which, when positioned correctly, can immensely improve disease perception and understanding to enhance patient care. The project will prioritise the needs and wants of modern-day patients, focused on providing easily accessible and noninvasive therapeutic options. Combining all these elements in a well-coordinated project is pivotal to relieving the heavy burden endometriosis places on European society as a whole.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

EUmetriosis will generate new knowledge in the field of endometriosis, its drivers and consequences, as well as biological determinants, which will result in a better understanding of endometriosis pathogenesis and the factors involved. Specifically, the project will assess the role of the immune cells, diet, cognitive behaviour and other related factors in disease pathogenesis, and develop strategies on how to alleviate endometriosis-associated pain, enhance quality of life and improve outcomes for patients. The knowledge base (like the association between nutrition, epigenetics, the microbiome and endometriosis) and methodologies generated within the project will drive the fields of gynaecology, primary care, pain medicine, urology and gastroenterology forward. Finally, through the collection of evidence for effective self-management strategies, the project will pave the path for more patient-tailored health policies. The project aims to link different stakeholder groups involved in this field, like clinicians, patients, healthcare insurers/payers and other researchers in women's health. With this multidisciplinary consortium, EUmetriosis will maximise its impact by creating therapeutic and diagnostic endometriosis solutions best suited to real-world applications, with a clear strategy for implementation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometriosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

pre-menopausal adult women with clinically and/or ultrasound-diagnosed endometriosis, age between 18 and 40 years, with regular menstruation, without autoimmune diseases, without malignant diseases

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women with a clinical and/or ultrasound diagnosis of endometriosis who are candidates for surgery
* Age between 18 and 50 years
* Pre-menopausal status
* Experiencing regular menstruation
* Willing to collect menstrual effluent
* Signature of informed consent to the study

Exclusion Criteria

* Age below 18 years
* Post-Menopausal status
* Presence of Crohn's disease
* Presence of Ulcerative Colitis
* Presence of short bowel syndrome or another chronic inflammatory disease
* Use immunosuppressive medication
* Receiving contraceptive hormone therapy
* Pregnant
* Presence/history of malignancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Commission

OTHER

Sponsor Role collaborator

Medical University of Lublin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Iwona Wertel

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jarogniew Ɓuszczki, professor

Role: STUDY_DIRECTOR

UNIWERSYTET MEDYCZNY W LUBLINIE

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marek Gogacz, professor

Role: CONTACT

Iwona Wertel, professor

Role: CONTACT

Related Links

Access external resources that provide additional context or updates about the study.

https://cordis.europa.eu/project/id/101157146

CORDIS belongs to the Research and Innovation community platform of the European Commission and complements the Funding and tender opportunities website, where there is possibility to apply for funding and search for partners.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Project 101157146-EUmetriosis

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

101157146

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pentoxifylline and Endometriosis
NCT00632697 COMPLETED PHASE3